Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
株式のランク #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
株価
$2.69
時価総額
$40.34M
変化(1日)
-1.47%
変化(1年)
-48.27%
US
取引 Serina Therapeutics, Inc. (SER)

カテゴリー

Serina Therapeutics, Inc.(SER)の配当利回りの履歴
Serina Therapeutics, Inc.(銘柄コード: SER)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Serina Therapeutics, Inc.(SER)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)